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ABSTRACT Copper (Cu) is an essential metal for bacterial physiology but in excess
it is bacteriotoxic. To limit Cu levels in the cytoplasm, most bacteria possess a tran-
scriptionally responsive system for Cu export. In the Gram-positive human pathogen
Streptococcus pyogenes (group A Streptococcus [GAS]), this system is encoded by the
copYAZ operon. This study demonstrates that although the site of GAS infection rep-
resents a Cu-rich environment, inactivation of the copA Cu efflux gene does not re-
duce virulence in a mouse model of invasive disease. In vitro, Cu treatment leads to
multiple observable phenotypes, including defects in growth and viability, decreased
fermentation, inhibition of glyceraldehyde-3-phosphate dehydrogenase (GapA) activ-
ity, and misregulation of metal homeostasis, likely as a consequence of mismetala-
tion of noncognate metal-binding sites by Cu. Surprisingly, the onset of these effects
is delayed by 4 h even though expression of copZ is upregulated immediately
upon exposure to Cu. Further biochemical investigations show that the onset of all
phenotypes coincides with depletion of intracellular glutathione (GSH). Supplemen-
tation with extracellular GSH replenishes the intracellular pool of this thiol and sup-
presses all the observable effects of Cu treatment. These results indicate that GSH
buffers excess intracellular Cu when the transcriptionally responsive Cu export sys-
tem is overwhelmed. Thus, while the copYAZ operon is responsible for Cu homeosta-
sis, GSH has a role in Cu tolerance and allows bacteria to maintain metabolism even
in the presence of an excess of this metal ion.
IMPORTANCE The control of intracellular metal availability is fundamental to bacte-
rial physiology. In the case of copper (Cu), it has been established that rising intra-
cellular Cu levels eventually fill the metal-sensing site of the endogenous Cu-sensing
transcriptional regulator, which in turn induces transcription of a copper export
pump. This response caps intracellular Cu availability below a well-defined threshold
and prevents Cu toxicity. Glutathione, abundant in many bacteria, is known to bind
Cu and has long been assumed to contribute to bacterial Cu handling. However,
there is some ambiguity since neither its biosynthesis nor uptake is Cu-regulated.
Furthermore, there is little experimental support for this physiological role of gluta-
thione beyond measuring growth of glutathione-deficient mutants in the presence
of Cu. Our work with group A Streptococcus provides new evidence that glutathione
increases the threshold of intracellular Cu availability that can be tolerated by bacte-
ria and thus advances fundamental understanding of bacterial Cu handling.
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Bacteria have been exposed to environmental copper (Cu) since the Great OxidationEvent, when the rise in atmospheric O2 levels led to its solubilization from minerals.
There is also evidence that recent evolution of plant, animal, and human pathogens has
been influenced by the anthropogenic release of Cu into soils, for instance via mining
activities and the legacy of using Cu salts and compounds in industrial-scale biocides
(1). In addition, bacteria encounter elevated levels of Cu in microenvironments within
a eukaryotic host. Bacterial predation induces an increase in intracellular Cu levels in
protozoa (2), while phagocytosis stimulates uptake and accumulation of Cu in murine
macrophages (3, 4). Studies of more complex animal models of infectious disease and
human infections further suggest that infection triggers systemic changes in host Cu
levels and that the specific sites of inflammation are usually, though not always, Cu-rich
(5–9). The prevailing model is that Cu exerts a direct antibacterial action and/or
supports the antibacterial function of innate immune cells (10).
Cu can be bacteriotoxic because it is a thermodynamically competitive metal for
protein binding (11). Extracellular Cu invariably enters the bacterial cytoplasm via
uptake processes that remain poorly understood. Once inside, Cu fills the available
Cu-binding sites in proteins and other biomolecules, beginning with the tightest
affinity and eventually associating with the weakest affinity sites. Within this hierarchy
of binding sites are the allosteric sites in Cu-sensing transcriptional regulators, which,
when metalated by Cu, activate expression of a Cu efflux pump (12). In undertaking this
role, the Cu sensor and export pump together impose an upper threshold of Cu
availability in the cytoplasm. This system ensures that only native, stable, high-affinity
Cu sites are metalated by Cu, and at the same time, prevents adventitious, nonspecific,
noncognate, weaker-binding sites from becoming mismetalated. Such mismetalation
events can inactivate key enzymes and, consequently, impair bacterial growth and
viability (13–16).
Additional cytoplasmic components are thought to limit Cu availability by chelating
or “buffering” this metal ion. These components include bacterial metallothioneins (17),
Cu storage proteins (18), and Cu-binding metallochaperones (19, 20), which are often,
though not always, transcriptionally regulated by the endogenous Cu sensors. Mutant
bacterial strains lacking these proteins typically display a Cu-sensitive growth pheno-
type. Non-protein components, particularly the low-molecular-weight thiol glutathione
(GSH), are also assumed to buffer Cu (21), although their uptake or biosynthesis is not
transcriptionally induced in response to Cu treatment (15, 20, 22, 23). Addition of GSH
protects purified metalloenzymes from inactivation by Cu (13). Growth of bacterial
mutant strains that are impaired in GSH uptake (24) or biosynthesis (25–27) are all
inhibited by added Cu, especially if the Cu efflux pump (25, 26) or Cu-binding metal-
lochaperone (27) in the organism is also inactivated.
Beyond growth analysis, there is currently little experimental support for a physio-
logical role of GSH in buffering Cu in bacteria. Perhaps the clearest, albeit indirect, line
of evidence was obtained using a ΔgshB Δatx1 mutant of Synechocystis lacking the GSH
biosynthesis enzyme GshB and the cytoplasmic Cu-binding metallochaperone Atx1.
This mutant failed to repress expression of Zn-regulated genes in response to elevated
Zn (27). In vitro metal- and DNA-binding experiments (28) suggest that the absence of
GSH and the metallochaperone leads to an increase in intracellular Cu availability,
which mismetalates the allosteric site of the Zn sensor Zur and thus interferes with Zn
sensing.
Like most bacteria, the Gram-positive human pathogen Streptococcus pyogenes
(group A Streptococcus [GAS]) possesses a system for Cu sensing and efflux, which is
encoded by the copYAZ operon (29). In this work, we examine whether copA, encoding
the Cu-effluxing P1B-1-type ATPase, plays a critical role in GAS pathogenesis, as dem-
onstrated for other bacterial pathogens (7, 30–32). We show that GAS occupies a
Cu-rich environment during infection of a mouse model of invasive disease, and yet
inactivation of copA does not significantly reduce GAS virulence. This unexpected
observation leads us to investigate the effects of Cu treatment on the cellular biochem-
istry and physiology of GAS. The results provide key insights into the importance of GSH
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in cytoplasmic Cu buffering to supplement the transcriptionally responsive Cu sensing
and efflux system. This additional buffering extends the range of intracellular Cu
concentrations that can be tolerated by bacteria and thus prevents a sudden or abrupt
transition from Cu homeostasis to Cu stress upon exposure to an excess of this metal
ion.
RESULTS
Initial characterization of a copA mutant. The copYAZ operon in GAS has been
previously shown to resemble other Cop systems in Gram-positive bacteria (29) (see
Fig. S1A in the supplemental material). Consistent with a role in Cu efflux, expression
of this operon functionally complemented a heterologous Escherichia coli ΔcopA mu-
tant strain (29). In silico analyses found one additional open reading frame downstream
of copZ (see Fig. S1A). It encodes a small, uncharacterized protein (56 amino acids) with
an N-terminal transmembrane domain, a putative metal-binding C-X3-M-H motif at the
C terminus, and no characterized homologue. This gene is absent from copYAZ operons
in other Gram-positive bacteria and its function in Cu homeostasis is unknown.
For the present study, a non-polar ΔcopA mutant of GAS M1T1 strain 5448 was
constructed. This mutation did not alter basal expression of downstream cop genes (see
Fig. S1Bi). As anticipated, the ΔcopA mutant was more susceptible to growth inhibition
by added Cu than was the wild type (see Fig. S1C). This mutant also accumulated more
intracellular Cu (see Fig. S1D), leading to increased expression of the other cop genes
compared to the wild type (see Fig. S1Bii). Marker rescue (copA) restored the expres-
sion of both copA and wild-type phenotypes (see Fig. S1B to D).
Deletion of copA does not lead to a loss of virulence in a mouse model of
infection. To determine whether the Cop system and its interactions with host Cu have
an effect on GAS pathogenesis, an established invasive disease model using transgenic
human-plasminogenized mice was used (33). Mice subcutaneously infected with wild-
type GAS developed ulcerative skin lesions at the site of injection after 1 day. These
lesions were excised 3 days post-infection and were found to contain more Cu than
adjacent healthy skin or skin from uninfected mice (Fig. 1A). Consistent with these
results, the copYAZ operon was upregulated in GAS isolated from infected mouse
tissues compared to those grown in THY medium (34). There was also an increase in Cu
levels in mouse blood after 3 days of infection (Fig. 1B). Notably, these Cu levels in the
blood are comparable to those measured in the sera of mice infected with the fungal
pathogen Candida albicans or the parasite Plasmodium berghei (5). These observations
support a model where redistribution of host Cu is a feature of the general immune
response to infection (5).
Comparing the survival of mice post-infection, no statistically significant difference
was observed whether mice were infected with the wild type or the copA mutant
(P  0.0991; Fig. 1C). Although no single animal model can fully represent the complex
features of human streptococcal diseases (35), consistent with in vivo findings, the
ΔcopA mutant was no more susceptible to killing by human neutrophils compared with
the wild-type or copA mutant strains in an ex vivo infection assay (Fig. 1D). In addition,
recent reports did not identify the cop genes to be fitness determinants during ex vivo
infection of human blood (36) or in vivo soft tissue infection in mice (37). These results
imply that, despite the systemic and niche-specific elevated levels of host Cu, the Cu
efflux pump CopA is not essential for GAS virulence in this model.
Cu treatment leads to defects in the late exponential phase of growth. The lack
of a virulence defect for the copA mutant in vivo prompted us to examine the impact
of Cu treatment on GAS physiology in vitro. Addition of Cu (up to 10 M) to the culture
medium did not affect the doubling time of the ΔcopA mutant during the exponential
phase of growth, but it did reduce the final culture yield (Fig. 2A; see Fig. S2A and B).
This phenotype was reproduced during growth in the presence of glucose or alterna-
tive carbon sources (see Fig. S2C). Under each condition, growth of Cu-treated cultures
ceased upon reaching approximately the same optical density at 600 nm (OD600;
0.35) regardless of growth rate, indicating that the growth defect was related to
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bacterial cell numbers and/or growth stage. Consistent with this interpretation, Cu
treatment did not affect growth in the presence of mannose (see Fig. S2C) or limiting
amounts of glucose (see Fig. S2D), since neither experimental condition supported
growth of GAS beyond an OD600 of 0.35.
Parallel assessments of plating efficiency and total ATP levels confirmed that differ-
ences between Cu-treated and untreated cultures appeared only in the late exponen-
tial or early stationary phase of growth (after 4 h when grown in the presence of
glucose; Fig. 2B and C). There were clear decreases in the plating efficiency and ATP
production by Cu-treated ΔcopA cultures during this period compared to the untreated
control.
Cu treatment leads to metabolic arrest in the late exponential phase of growth.
GAS is a lactic acid bacterium. Under our experimental conditions, this organism carried
out homolactic fermentation and generated lactic acid as the major end product (see
Fig. S3A and B). However, Cu-treated ΔcopA cultures did not acidify the growth medium
(see Fig. S3C), leading us to hypothesize that Cu treatment impairs fermentation in GAS.
Consistent with this proposal, Cu-treated ΔcopA cultures produced 50% less lactic
acid and consumed 50% less glucose compared to the untreated control (Fig. 3A; see
also Fig. S3Bi and ii). Pyruvate production remained unchanged (see Fig. S3Biii). There
is no evidence of a shift toward mixed-acid fermentation since the reduction in lactate
FIG 1 Changes in Cu levels during GAS infection and the effect of a copA mutation on GAS virulence in
host infection models. (A) Cu levels in mouse lesions. Mice were infected subcutaneously with GAS
wild-type strain or left uninfected (n  10 each). After 3 days, skin from uninfected mice, and both skin
lesions and healthy skin adjacent to the lesions from infected mice were excised. Total Cu levels were
measured by ICP-MS and normalized to the weight of the tissues. Cu levels in infected lesions were
higher than those in adjacent healthy skin (P  0.0001) or skin from uninfected mice (P  0.0001). (B)
Cu levels in mouse blood. Mice were infected subcutaneously with GAS wild-type strain or left uninfected
(n  10 each). Blood was collected and total Cu levels were measured by ICP-MS. Values below the
detection limit were represented as zero. Cu levels in the blood of infected mice on days 1 and 3 were
higher from those in the blood of uninfected mice (***, P  0.0001; ****, P  0.0001). ns, P  0.81 (versus
uninfected mice). (C) Virulence in an in vivo mouse model of infection. Mice were infected subcutane-
ously with GAS wild-type (WT) or ΔcopA mutant strains (n  10 each). The number of surviving mice was
counted daily up to 10 days post-infection. Differences in survival curves were analyzed using the
Mann-Whitney test, which found no statistical difference (P  0.099). (D) Virulence in an ex vivo human
neutrophil model of infection. Human neutrophils were infected with GAS wild-type (WT), ΔcopA, or
copA strains (n  3 each). Survival of bacteria relative to the input was measured after 0.5 h. There was
no difference between survival of the ΔcopA mutant compared with the WT (P  0.87) or copA (P 
0.35) strains.
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levels was not accompanied by a concomitant increase in acetate levels (see Fig. 3Biv).
Ethanol levels were undetectable (detection limit, 0.2 mM).
Differences in lactate production between Cu-treated and untreated ΔcopA cultures
appeared, again, only after 4 h of growth (Fig. 3A). While our methods are not
sufficiently sensitive to detect small changes in glucose levels at earlier time points, it
is clear that Cu-treated ΔcopA cultures did not consume glucose beyond t  4 h (see
Fig. S3Di). Pyruvate production was, again, not affected at any time point (see
Fig. S3Dii). These results suggest that Cu treatment leads to defects in metabolism but
only after entry into the late exponential phase of growth.
Cu treatment results in a loss of GapA activity in the late exponential phase of
growth. The loss of lactate production, but not pyruvate, implies that lactate dehy-
drogenase (Ldh) is inactivated (Fig. 3B). To test this proposal, we cultured GAS in the
absence or presence of added Cu for 4 h, prepared whole-cell extracts, and measured
Ldh activity. Figure 3Ci and 3Di show that Ldh remained active in all strains, regardless
of Cu treatment.
What, then, is the target of Cu intoxication in GAS? This bacterium does not possess
a tricarboxylic acid cycle or the biosynthesis pathways for multiple amino acids,
vitamins, and cofactors (e.g., heme). Thus, it lacks obvious candidate iron-sulfur cluster
enzymes that are destabilized by excess Cu ions in other systems (13). In an attempt to
develop a molecular explanation for the loss of fermentation, the activity of the two
FIG 2 Cu-dependent defects in growth and viability. GAS strains were cultured with added Cu as
indicated. (A) Growth. Cultures (n  3) were grown in microtiter plates and OD600 values were recorded
every 20 min. Cu treatment suppressed growth of ΔcopA cultures (P  0.034 for 5 M Cu, P  0.0001 for
10 M Cu). (B) Plating efficiency. Cultures (n  3) were plated out at the indicated time points and the
number of CFU was enumerated. Cu treatment suppressed plating efficiency of the ΔcopA cultures (P 
0.0001 for both 0.5 and 5 M Cu). (C) Total ATP levels. Cultures (n  5) were sampled at the indicated
time points and total ATP levels were determined. Cu treatment suppressed ATP production in the ΔcopA
cultures (P  0.0001). All statistical analyses were versus 0 M Cu.
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GAPDH (glyceraldehyde-3-phosphate dehydrogenase) enzymes in GAS, namely, the
classical, phosphorylating, ATP-generating GapA and the alternative, nonphosphory-
lating GapN, was examined (Fig. 3B). GapA has been identified as a target of Ag and Cu
poisoning in E. coli (38) and Staphylococcus aureus (39), respectively, and as such, it is
a likely candidate for Cu poisoning in GAS. As expected, Cu treatment led to a decrease
in GapA activity in ΔcopA mutant cells (Fig. 3Cii and Dii), which would explain the
reduction in lactate secretion (Fig. 3A) and ATP production (Fig. 2C). The reduction in
GapA activity would also cause upstream glycolytic precursors to accumulate, with
consequent feedback inhibition of downstream enzymes (40), as well as glucose
phosphorylation and uptake (see Fig. S3Bii and S3Di) (41, 42).
This Cu-dependent inhibition is specific to GapA since there was no reduction in
GapN activity (Fig. 3Ciii and Diii). Given that there was no detectable change in GapA
protein levels in cell extracts (see Fig. S3E), these observations are consistent with
mismetalation of GapA, as established recently for the GapA homologue in S. aureus
(39). The excess Cu ions likely bind to the conserved Cys and His residues at the catalytic
site, as suggested previously for the binding of Ag ions to GapA from E. coli (38).
FIG 3 Cu-dependent defects in glycolysis and homolactic fermentation. (A) Lactate production. GAS strains were cultured with added
Cu as indicated (n  3). Amounts of lactate secreted to the extracellular culture medium were measured at the indicated time points.
Cu treatment suppressed lactate production in the ΔcopA cultures (P  0.0001). (B) Fermentation pathway in GAS. Enzymes of interest,
namely, GapA (NAD-dependent GAPDH, M5005_SPy_0233), GapN (NADP-dependent GAPDH, M5005_SPy_1119), and Ldh (lactate
dehydrogenase, M5005_SPy_0873) are shown. (C and D) Activity of glycolytic enzymes Ldh (i), GapA (ii), and GapN (iii). GAS strains
were cultured for t  4 h with 0 or 1 M added Cu (n  3) (C) or 0 or 5 M added Cu (n  4) (D). Enzyme activities were determined
in cell extracts. Cu treatment decreased GapA activity in ΔcopA cultures (***, P  0.0004). ns, P  0.14. (E) GapA activity over time. GAS
ΔcopA mutant strain was cultured with added Cu as indicated for t  2 h (n  3), 3 h (n  7), or 4 h (n  7). Enzyme activities were
determined in cell extracts. Cu treatment did not have an effect on GapA activity at t  2 h (P  0.99) or 3 h (ns, P  0.18), but it
strongly inhibited GapA activity at t  4 h (P  0.0001). All statistical analyses were versus 0 M Cu.
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Remarkably, when cultures were sampled earlier (at t  2 and 3 h), no difference was
observed between GapA activity in Cu-treated and control ΔcopA cells (Fig. 3E). The
timing of GapA inhibition, i.e., at the onset of the late exponential phase of growth (at
t  4 h; Fig. 3E), coincided with the arrest in bacterial growth and metabolism, sup-
porting the hypothesis that GapA is a key target of Cu intoxication in GAS.
Cu treatment leads to misregulation of metal homeostasis in late exponential
phase of growth. The puzzling but consistent, 4-h delay in the onset of all observable
phenotypes led us to hypothesize that there was a time-dependent shift in Cu handling
by GAS. To test this proposal, the response of the Cu sensor CopY was measured by
monitoring expression of copZ during growth in the presence of the lowest inhibitory
concentration of added Cu (0.5 M; see Fig. S2Aii). The results show that copZ tran-
scription was upregulated 4-fold immediately upon Cu exposure (t  0 h, in which
12 min passed between the addition of Cu into the culture, centrifugation, and the
addition of lysis buffer; Fig. 4A). This level of upregulation remained largely unchanged
during growth (measured up to 5 h; Fig. 4A), even though intracellular Cu levels
continued to rise (see Fig. S4). These results suggest that the CopY sensor became fully
metalated and expression of copZ reached its maximum at t  0 h post-challenge with
added Cu. These data also establish that the copYAZ operon is transcriptionally induced
before the onset of observable growth defects (hereafter referred to as Cu “stress”).
We concurrently measured the expression of genes that are controlled by other
metalloregulators, namely adcAII (regulated by AdcR, a MarR-family Zn-sensing tran-
scriptional corepressor [43]), siaA (controlled by MtsR, a DtxR-family Mn/Fe-sensing
corepressor [44]), and cadD (regulated by CadC, an ArsR-family Zn/Cd-sensing dere-
pressor [45]). Clear changes in the expression levels of all three genes were detected in
response to Cu treatment. While adcAII and siaA were downregulated, cadD was
upregulated (Fig. 4B to D). Each of these transcriptional responses indicates metalation
of the corresponding metallosensor (Fig. 4B to D), but whether by the cognate metal
or by Cu cannot be distinguished. These observations were further corroborated by
results from genome-wide RNA sequencing (RNA-seq) analyses. Multiple AdcR- and
MtsR-controlled genes were negatively regulated, while both the CadC-controlled
genes were positively regulated in response to 5 M added Cu (Table 1; see Data Set
S1). Interestingly, no clear effect on gczA or czcD expression was detected, suggesting
that the metalation status of GczA, a TetR-family Zn-sensing derepressor (46), is not
altered by Cu treatment.
Crucially, changes in the expression of adcAII, siaA, and cadD appeared only after 4
h of growth (Fig. 4B to D). These transcriptional changes were not accompanied by
increases in total intracellular Zn, Mn, or Fe levels (see Fig. S4). Thus, the simplest model
that accounts for the sudden metalation (or mismetalation) of multiple metallosensors,
as well as GapA, is that excess Cu is released from an intracellular buffer, leading to
mislocation of Cu to adventitious binding sites and/or redistribution of intracellular
metals.
The onset of the Cu stress phenotype coincides with depletion of GSH. What
comprises the intracellular buffer for excess Cu in GAS? This organism does not possess
a homologue of the metallothionein MymT (17) or the Cu storage protein Csp (47).
Instead, this buffer likely consists of a polydisperse mixture of cytoplasmic small
molecules or metabolites (48). Noting that GAS is auxotrophic for most nutrients,
including multiple amino acids, vitamins, nucleobases, and GSH, we hypothesized that:
(i) one or more of these nutrients constitute the intracellular Cu buffer, either directly
by coordinating Cu or indirectly by acting as a synthetic precursor to the buffer, and
that (ii) these nutrients become exhausted from the extracellular medium during
bacterial growth, leading to the observable effects of Cu stress.
The above hypothesis was tested using two complementary approaches and the
results identified GSH as the key limiting nutrient. First, mass spectrometry was em-
ployed to measure consumption of nutrients from the growth medium. Several amino
acids, the nucleobases adenine and uracil, as well as GSH (and/or its disulfide GSSG)
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were nearly or completely spent after 4 h of growth (see Fig. S5). Cys and its disulfide
were below detection limits. Next, the culture medium was supplemented with each or
a combination of the spent or undetected extracellular nutrients. Their ability to restore
growth of Cu-treated ΔcopA mutant cultures was subsequently examined. Only sup-
plementation with GSH was strongly protective against Cu intoxication (see Fig. S6).
The GAS genome encodes neither the common pathway for GSH biosynthesis
(GshAB) nor the bifunctional glutathione synthetase (GshF [49]). Instead, an uncharac-
terized homologue of the GSH-binding solute-binding protein GshT is present
(M5005_Spy0270, 59% sequence identity, 74% sequence similarity with the character-
ized homologue from S. mutans) (50). GshT, in conjunction with the endogenous
FIG 4 Cu-dependent misregulation of metal homeostasis genes. GAS ΔcopA mutant strain was cultured
with or without added 0.5 M Cu for the indicated times (n  4). Transcript levels in Cu-treated cultures
were determined by qPCR and normalized to the corresponding untreated samples that were cultured
for the same time periods. Dotted horizontal lines represent the limit of the assay (log2FC  0.5). A
schematic representation of each gene and its cognate metallosensor is shown. Transcription of copZ or
cadD is derepressed upon binding of Cu to CopY or Zn (or Cd) to CadR, respectively. Transcription of
adcAII or siaA is repressed upon binding of Zn to AdcR or Mn (or Fe) to MtsR, respectively. (A) copZ. Cu
treatment induced copZ expression t  0 h (P  0.0037 versus log2FC  0). This magnitude of induction
remained unchanged over the growth period (ns, P  0.53, 0.94, 0.47, and 0.90 for t  2, 3, 4, and 5 h,
respectively, versus t  0 h). (B) cadD. Cu treatment upregulated cadD expression at t  4 and 5 h (P 
0.0044 and  0.0001, respectively, versus log2FC  0). (C) adcAII. Cu treatment downregulated adcAII
expression at t  4 and 5 h (P  0.035 and 0.0004, respectively, versus log2FC  0). (D) siaA. Cu treatment
downregulated siaA expression at t  3, 4, and 5 h (P  0.014, 0.012, and 0.084, respectively, versus
log2FC  0).
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cystine importer TcyBC, likely allows GAS to import extracellular GSH (-Glu-Cys-Gly)
into the cytoplasm (50). This system may also import -Glu-Cys or Cys-Gly (50), but
addition of these dipeptides, or Cys alone, or a mixture of the amino acids Glu, Cys, and
Gly did not improve growth of Cu-treated ΔcopA mutant cultures (Fig. 5A). Altogether,
these results suggest that: (i) the protective effect of GSH is unlikely to result from
chelation of extracellular Cu ions by free thiols, (ii) extracellular GSH is depleted during
growth of GAS, and (iii) this depletion is responsible for the observable Cu stress
phenotypes. Consistent with propositions ii and iii, addition of GSH completely sup-
pressed the effects of Cu treatment and restored plating efficiency, as well as glucose
consumption, lactate secretion, and ATP production beyond the late exponential phase
of growth (Fig. 5B to E).
GSH contributes to buffering of excess intracellular Cu. To test that the protec-
tive effect of GSH is not linked to chelation of extracellular Cu ions and decreased
uptake of Cu into the cytoplasm, total intracellular Cu levels were measured in ΔcopA
mutant cultures that were supplemented with Cu and/or GSH. As expected, GSH
supplementation did not suppress total intracellular Cu levels when ΔcopA cultures
TABLE 1 Cu treatment leads to a misregulation of metal homeostasisa
Gene MGAS5005 gene product annotation Log2FC(Cu/–Cu) Padj
CopY regulated
copZ Copper chaperone 4.41 0.0000
copA Copper-exporting ATPase 4.39 0.0000
copY CopAB ATPase metal-fist type repressor 4.49 0.0000
CadC regulated
cadD Cadmium resistance protein 3.15 0.0000
cadC Cadmium efflux system accessory protein 4.00 0.0000
AdcR regulated
phtY Internalin protein 1.80 0.0000
rpsN 30S ribosomal protein S14 1.72 0.0000
phtD Histidine triad protein 2.51 0.0000
adcAII Laminin-binding protein 2.37 0.0000
adhE Acetaldehyde-CoA/alcohol dehydrogenase 3.32 0.0000
MtsR regulated
fhuG Ferrichrome transporter permease 1.99 0.0000
fhuB Ferrichrome transporter permease 1.81 0.0000
fhuD Ferrichrome-binding protein 1.91 0.0000
fhuA Ferrichrome ABC transporter ATP-binding protein 1.75 0.0000
nrdI.2 Ribonucleotide reductase stimulatory protein 1.57 0.0006
nrdE.2 Ribonucleotide-diphosphate reductase subunit alpha 1.64 0.0001
hupY Cell surface protein 2.29 0.0000
hupZ Hypothetical protein M5005_Spy_0652 2.25 0.0000
siaD ABC transporter ATP-binding protein 2.34 0.0000
siaC Ferrichrome ABC transporter ATP-binding protein 2.71 0.0000
siaB Ferrichrome transporter permease 2.63 0.0000
siaA Ferrichrome-binding protein 2.28 0.0000
shp Heme-binding protein 1.80 0.0000
shr Fe3-siderophore transporter 1.94 0.0000
GczA regulated
gczA TetR family transcriptional regulator 0.03 0.9378
czcD Cobalt-zinc-cadmium resistance protein 0.46 0.2807
GSH import
gshT Amino acid ABC transporter substrate-binding protein 0.90 0.1098
tcyB Amino acid ABC transporter permease 0.83 0.0409
tcyC ABC transporter substrate-binding protein 0.87 0.0443
aGAS ΔcopA mutant strain was cultured with or without 5 M added Cu for t  5 h (n  3). Total RNA was extracted, rRNA was depleted, and cDNA was generated
and finally sequenced by Illumina. Differential gene expression was determined using DeSeq2 and is presented as the fold change (FC) in gene expression in the Cu-
treated cultures relative to that in the untreated control. Only genes of interest are listed. These are genes regulated by metal-sensing transcriptional regulators
CopY, CadC (45), AdcR (43), MtsR (44), and GczA (46), as well as those that encode components of the putative GSH uptake system (50). A complete list of
differentially regulated genes is provided in Data Set S1.
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were challenged with low concentrations of added Cu (500 nM; Fig. 6A). Surprisingly, at
high concentrations of added Cu (5 M), GSH-replete cultures appeared to accumulate
higher, rather than lower, intracellular Cu levels (Fig. 6A). Yet, these cultures did not
display an observable Cu stress phenotype (Fig. 5). These findings are discussed below.
The time-dependent reduction in extracellular GSH levels (see Fig. S5D) was mir-
rored by a decrease in intracellular GSH (Fig. 6Bi). Both the wild-type and ΔcopA mutant
strains contained 4 mM intracellular GSH (and GSSG) at t  0 h (Fig. 6Bi). This amount
was likely already present in the inoculum, which was cultivated in the complex
medium THY ([GSH]THY  30 M [51]). Intracellular GSH levels in both strains reduced
to 0.1 mM at t  4 h, regardless of Cu treatment (Fig. 6Bi and ii). This decrease
occurred presumably as a consequence of bacterial growth and replication in a
chemically defined medium with a limited GSH supply ([GSH]CDM  0.5 M; see
Fig. S5D). The low amount of intracellular GSH coincided with the onset of the
observable Cu stress phenotypes. It might also explain why cultures that grew to low
OD600 values displayed no sign of Cu stress (see Fig. S2C and D); these cultures likely
had not depleted their intracellular GSH supply.
FIG 5 Protective effects of supplemental GSH. GAS ΔcopA mutant strain was cultured with added Cu as indicated (n  3) in
the absence (black) or presence (blue) of 0.1 mM GSH. (A) Growth. Cu treatment did not affect GSH-supplemented cultures
(P  0.99). Growth curves in culture medium supplemented with water; a mixture of Glu, Cys, and Gly (0.1 mM each); Cys alone
(0.1 mM); the dipeptide -GluCys (0.1 mM); or CysGly (0.1 mM) are also shown for comparison. (B) Plating efficiency. Cultures
were plated out at the indicated time points and the numbers of CFU were enumerated. Cu treatment suppressed plating
efficiency of GSH-deplete cultures (P  0.0012) but not that of the GSH-supplemented cultures (P  0.97). (C) Glucose
consumption. Cultures were sampled at t  8 h, and total amounts of glucose consumed from the extracellular growth media
were determined. Cu treatment suppressed glucose consumption by GSH-deplete cultures (P  0.0053 for 1 M Cu,
P  0.0001 for 5 M Cu) but not that by GSH-supplemented cultures (P  0.12 for 1 M Cu, P  0.81 for 5 M Cu). (D) Lactate
production. Cultures were sampled at t  8 h, and the amounts of lactate secreted to the extracellular growth media were
determined. Cu treatment suppressed lactate production by GSH-deplete cultures (P  0.11 for 1 M Cu, P  0.014 for 5 M
Cu) but not that by GSH-supplemented cultures (P  0.91 for 1 M Cu, P  0.99 for 5 M Cu). (E) Total ATP levels. Cultures
were sampled at t  8 h and total ATP levels were determined. Cu treatment suppressed ATP production by GSH-depleted
cultures (P  0.0001 each for 1 and 5 M Cu) but not that by the GSH-supplemented cultures (P  0.095 for 1 M Cu, P 
0.0008 for 5 M Cu). All statistical analyses were versus 0 M Cu.
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Notably, Cu treatment did not transcriptionally induce the uptake of GSH. Levels of
gshT transcripts remained largely unchanged, based on RNA-seq analyses of copA
cells at the late-exponential phase of growth (Table 1). This result supports previous
transcriptomic studies in several Gram-positive and Gram-negative bacteria, none of
which identified GSH biosynthesis or uptake as a key transcriptional response to Cu
treatment (15, 20, 22, 23).
Supplementation of the growth medium with GSH (0.1 mM) did not affect the
intracellular levels of this thiol at the early stages of growth (t  0 and 2 h; Fig. 6Bii).
FIG 6 Buffering of excess intracellular Cu ions by GSH. GAS ΔcopA mutant strain was cultured with added Cu as indicated, without
(black) or with (blue) 0.1 mM added GSH. The following properties were subsequently measured. (A) Intracellular Cu levels. Cultures
(n  3) were harvested at t  4 h, and total cellular levels of Cu were measured by ICP-MS. GSH supplementation did not affect
intracellular Cu levels when cultures were treated with 0 (P  1) or 0.5 M Cu (P  0.92), but it did lead to an increase in Cu levels
when cultures were treated with 5 M Cu (P  0.0001). (B) Intracellular GSH concentrations. (i) Cultures (n  2) were prepared without
any added Cu or GSH and sampled at the indicated time points. Intracellular levels of GSH were measured in cell extracts. There was
no clear difference between the time-dependent decrease in intracellular GSH levels of WT and ΔcopA cultures. (ii) Cultures (n  3)
were sampled at the indicated time points and intracellular levels of GSH were measured in cell extracts. Cu treatment did not affect
intracellular GSH levels, regardless of GSH supplementation (P  0.95 for 0 mM GSH, P  1.0 for 0.1 mM GSH). GSH supplementation
improved intracellular GSH levels (P  0.0001 for both 0 and 0.5 M Cu), regardless of Cu treatment. (C) GapA activity. Cultures (n  3)
were harvested at t  4 h. GapA activity was measured in cell extracts. Cu treatment suppressed GapA activity in GSH-depleted
cultures (P  0.0007) but not in GSH-supplemented cultures (P  0.51). (D) Expression of metal homeostasis genes. GSH-
supplemented cultures (n  3) were sampled at the indicated time points. Levels of copZ, cadD, adcAII, and siaA transcripts in
Cu-treated cultures were determined by qPCR and normalized to the corresponding untreated samples that were harvested at the
same time points. Horizontal dotted lines represent the limit of the assay (log2FC  0.5). Cu treatment induced copZ expression
(P  0.023, 0.013, 0.026, and 0.093), but not cadD (P  0.17, 0.71, 0.98, and 0.32), or adcAII (P  0.39, 0.50, 0.03, and 0.16) at t  2,
3, 4, and 5 h, respectively (versus log2FC  0). Cu treatment continued to downregulate siaA expression (P  0.63, 0.03, 0.04, and 0.03
for t  2, 3, 4, and 5 h, respectively, versus log2FC  0). (E) Cu-dependent expression of copZ. Cultures (n  3) were sampled at t  4
h. Levels of copZ transcripts in Cu-treated cultures were normalized to the corresponding untreated samples. Horizontal dotted lines
represent the limit of the assay (log2FC  0.5). GSH supplementation did not affect copZ expression at low concentrations of added
Cu (ns, P  0.10, 0.14, 0.48, 1.0, and 0.31 for [Cu]  0, 25, 50, 125, and 500 nM), but it did affect expression at 1000 nM added Cu (***,
P  0.0009).
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However, it did allow ΔcopA cells to maintain intracellular concentrations of this
tripeptide at 1 mM (one log unit higher than unsupplemented cells) beyond the late
exponential growth phase, regardless of Cu treatment (Fig. 6Bii). As mentioned earlier,
these GSH-treated cells were Cu-tolerant (Fig. 5). In fact, these cells accumulated more
intracellular Cu compared with the GSH-untreated control (Fig. 6A). The simplest
explanation for this finding is that the rise in intracellular GSH levels leads to an
increased ability to buffer intracellular Cu. A more detailed examination of GSH-
supplemented ΔcopA cells confirmed that GapA was protected from inactivation by
added Cu (Fig. 6C). In addition, the Cu-induced, time-dependent changes in cadD and
adcAII expression were abolished (Fig. 6D), suggesting that CadC and AdcR did not
become mismetalated. Some downregulation of siaA transcription was observed, albeit
to a lesser magnitude compared with GSH-deplete cultures (Fig. 6D versus Fig. 4D). In
general, these results support a model whereby GSH constitutes the major buffer for
excess intracellular Cu in GAS and protects potential noncognate binding sites from
becoming (mis)metalated by Cu.
Importantly, GSH supplementation did not affect expression of copZ at low concen-
trations of added Cu (0 to 500 nM; Fig. 6E). This observation further strengthens the
proposal that GSH does not rescue the ΔcopA mutant simply by chelating extracellular
Cu ions. However, GSH treatment did partially suppress copZ expression in response to
a high concentration of added Cu (1,000 nM; Fig. 6E). This observation indicates the
relative buffering strengths of GSH and CopY, which are discussed below.
DISCUSSION
Role of GSH in buffering excess cytoplasmic Cu. GSH has been proposed to bind
Cu by assembling a stable, tetranuclear Cu4GS6 cluster (52). In such a model, when
present at low millimolar concentrations (e.g., 4 mM in GAS at t  0 h; Fig. 6A), GSH
would bind Cu with an apparent affinity of KD  1016.7 M and thus would impose a
threshold of Cu availability at 1016.7 M (see Fig. S7A). This threshold is above the range
of Cu availability set by most bacterial Cu sensors (see Fig. S7B) (53–55). Therefore, GSH
contributes to Cu buffering only when the transcriptionally responsive Cu homeostasis
system is impaired (e.g., in a ΔcopA mutant [25, 26]) or overwhelmed (e.g., when
intracellular Cu levels rise above the responsive range of the Cu sensors).
Figure 6E shows that supplementation with GSH had little impact on metalation of
CopY (and thus expression of copZ) when the amounts of added Cu were low. However,
GSH appeared to dampen CopY response at higher concentrations of added Cu,
indicating that this thiol competes with CopY for binding Cu when intracellular Cu
levels are high. Hence, the thresholds of intracellular Cu availability set by GSH and
CopY may overlap, at least partially, with GSH being the weaker buffer (52, 55, 56). The
thermodynamic model in Fig. S7B is compatible with these experimental data, but it
will need refinement. This model was estimated using known parameters (Cu affinity,
DNA affinity, and number of DNA targets) for CopY from S. pneumoniae (CopYSpn) (55),
but CopYSpn differs from CopYGAS in several key aspects. CopYSpn lacks one of the two
Cys-X-Cys motifs found in other CopY homologues such as CopYGAS and CopY from E.
hirae (CopYEh) (see Fig. S7D). CopYSpn binds two Cu atoms per dimer in a solvent-
exposed center while CopYEh binds four Cu atoms per functional dimer and assembles
a solvent-occluded center (55, 57). In addition, two cop boxes are present in S.
pneumoniae (58), while only one is found in GAS. How these differences shift the
threshold model will need to be examined using careful in vitro studies with purified
proteins and DNA. In the simplest scenario, an increase in the stability (affinity) of the
bound Cu atoms in CopY, which may occur as a consequence of coordination by extra
Cys ligands, would lower the threshold of Cu availability set by CopY (see Fig. S7C) and
thus better fit our experimental data.
Depletion of intracellular GSH to 0.1 mM at the late exponential phase of growth
would weaken its buffering capacity by at least 2 log units (see Fig. S7A). Figure 4 shows
that Cu is then able to metalate nonspecific binding sites in non-cognate metallosen-
sors or metalloenzymes. These results further suggest that AdcR, CadC, and MtsR can
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allosterically respond to Cu and differentially regulate expression of their target genes
in vivo. Precisely how this occurs will need to be confirmed with purified proteins and
DNA in vitro. Cu-responsive regulation of genes under the control of non-cognate
metallosensors has indeed been reported both in vivo and in vitro, although not for the
families of regulators described here (15, 28, 59–61).
Not all bacteria use GSH as the major cytoplasmic thiol. Some bacilli, such as B.
subtilis and S. aureus, produce the glycoside bacillithiol (BSH) instead. The affinity of BSH
to Cu is at least 2 orders of magnitudes tighter than that of GSH (56, 62). Hence, BSH
likely imposes a lower limit on cytoplasmic Cu availability than does GSH, but it is worth
noting that its intracellular level is 30 times lower than that of GSH (63). Importantly,
the relative order with the endogenous Cu sensor CsoR still holds, with BSH binding Cu
at least 3 log units more weakly than does CsoR (54). Indeed, this thiol is also thought
to contribute to Cu homeostasis by buffering excess Cu. Deletion of the B. subtilis bshC
gene for BSH biosynthesis led to a slight increase in copZ expression in response to
added Cu. This result mirrors the finding in Fig. 6E and suggests that the Cu sensor CsoR
is more readily metalated by Cu in the absence of the major buffering thiol (64). It is also
notable that the identification of GapA as a major reservoir of excess Cu ions in the
cytoplasm was in a strain of S. aureus that does not synthesize BSH (39).
In summary, this study provides a new line of evidence that Cu handling in the
bacterial cytoplasm, when formulated using the threshold model, comprises two
components (Fig. 7). The transcriptionally responsive component, which includes the
Cu sensor, Cu efflux pump, and additional Cu-binding metallochaperones, functions in
housekeeping or homeostasis and sets a low limit of Cu availability in the cytoplasm.
Rising Cu levels can saturate this homeostasis system and sudden Cu shock can
overwhelm it, but the transcriptionally unresponsive component, in this case GSH,
buffers the excess Cu and confers additional Cu tolerance. This second system acts as
the final layer of protection before cells experience widespread mismetalation and,
therefore, Cu stress (Fig. 7). This additional buffering essentially extends the range of
cytoplasmic Cu availability that can be tolerated by bacteria, allows bacteria to maintain
key cellular functions, and thus prevents an abrupt transition from Cu homeostasis to
Cu stress upon exposure to an excess of this metal ion. While this study focused
exclusively on a Gram-positive bacterial organism, this concept is likely to apply to
other bacterial systems and mammalian models (65).
Role of GSH in buffering bacterial Cu during host-pathogen interactions. This
study was conducted originally to examine the role of the Cop Cu homeostasis system
in GAS pathogenesis. Although GAS occupied a Cu-rich environment in mice (Fig. 1A),
FIG 7 Threshold model for bacterial Cu homeostasis, tolerance, and stress. As Cu levels in the cytoplasm
increase, this metal ion binds to the allosteric site of the Cu-sensing transcriptional regulator, which
subsequently induces expression of the Cu efflux pump. Together, the Cu sensor and efflux pump impose
a low limit of Cu availability and maintain Cu homeostasis. A further rise in cytoplasmic Cu levels
saturates the Cu homeostasis system and begins to fill binding sites in GSH. Since there are no observable
defects in bacterial metabolism or growth at this stage, GSH can be considered to confer Cu tolerance.
GSH depletion or a further increase in cytoplasmic Cu levels saturates this tolerance capacity. Cu now
binds to noncognate metal-binding sites, leading to inhibition of bacterial metabolism and growth.
These conditions are considered as Cu stress.
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inactivation of the copA gene did not lead to a reduction in GAS virulence (Fig. 1C). Our
in vitro investigations now suggest that GAS may withstand host-imposed increases in
Cu levels, as long as it has access to a source of GSH in vivo. Indeed, GSH was detected
in the skin ulcers of infected mice, but interestingly, the amount was 25-fold less
compared to skin from healthy mice or healthy skin from infected mice (see Fig. S8).
Whether this depletion of GSH is a feature of the general host immune response, a
consequence of inflammation and/or host tissue necrosis, or a consequence of GAS
metabolism is not known. Nevertheless, the virulence of the ΔcopA mutant implies that
the level of host GSH, albeit reduced, can support Cu buffering inside the GAS
cytoplasm. Alternatively, the level of host Cu (Fig. 1A) may not be sufficient to
overwhelm the Cop homeostasis system, since the copYAZ operon was only slightly
upregulated in bacteria isolated from mouse ulcers (average log2FC  1.13 versus THY)
(34).
Link between the failure to buffer Cu and redox stress. Under our experimental
conditions, untreated ΔcopA cells contained 17,000 to 23,000 Cu atoms when sampled
at t  3 h (before the onset of Cu stress). Cu treatment increased this number to 78,000
to 330,000 atoms (see Fig. S4). The intracellular GSH concentrations at the same time
point ([GSH]i  0.76 mM; Fig. 6B) would translate to 500,000 molecules of GSH, which
are clearly insufficient to buffer all of the intracellular Cu ions. However, there was no
observable Cu stress phenotype at this time point, suggesting that the excess Cu is also
bound to other cytoplasmic component(s). These components may include CopZ
and/or the novel, uncharacterized protein CopX (see Fig. S1A). This idea will be the
focus of future studies.
Finally, the GSH/GSSG couple is the major redox buffer of the cell. Assuming that the
GSH/GSSG ratio remains unchanged, depletion of intracellular GSH in GAS from 4 to
0.1 mM would raise the cytoplasmic redox midpotential by 46 mV. This relatively
more oxidizing environment, when combined with a lack of Cu buffering, may promote
the Cu-catalyzed generation of reactive oxygen species (66) or the formation of
disulfides (67). Yet, our RNA-seq results do not suggest widespread oxidative stress (see
Data Set S1). In E. coli, deletion of gshA did not accelerate DNA damage in Cu-replete
cells, even in the presence of added H2O2 (68). Similarly, proteomic analyses of a
non-BSH-producing strain of S. aureus indicated that Cu treatment does not induce a
strong oxidative stress response in this organism (39).
Regardless of the relative importance of mismetalation versus redox stress, our work
demonstrates that excess Cu is not bacteriotoxic as long as cytoplasmic GSH is
abundant and thus able to buffer the excess of this metal ion (Fig. 7). In GAS, a GSH
auxotroph, this intracellular buffer is dynamic; its levels change during bacterial growth
and/or in response to extracellular GSH availability. Future studies should take these
effects into account when examining the impact of Cu treatment on bacterial cultures.
Had our work not identified the 4-h time point as metabolically relevant, sampling
cultures 1 h earlier would have led to a different conclusion.
MATERIALS AND METHODS
Data presentation and statistical analyses. We follow recent recommendations regarding trans-
parency in data representation (69, 70). Except for growth curves, individual data points from indepen-
dent experiments are plotted, with shaded columns representing the means and error bars representing
standard deviations. Growth curves show the means of independent experiments, with shaded regions
representing standard deviations. The number of independent experiments is stated clearly in each
figure legend. Statistical analyses have been performed on all numerical data, but notations of statistical
significance are displayed on plots only if they aid in rapid, visual interpretation. Otherwise, P values for
key comparisons are stated in the figure legends. Unless otherwise stated, statistical tests used two-way
analysis of variance using the statistical package in GraphPad Prism 8.0. All analyses were corrected for
multiple comparisons.
Ethics statement. Animal experiments were conducted according to the Guidelines for the Care and
Use of Laboratory Animals (National Health and Medical Research Council, Australia) and were approved
by the University of Queensland Animal Ethics Committee (Australia). Human blood donation for use in
neutrophil killing studies was conducted in accordance with the National Statement on Ethical Conduct
in Human Research and in compliance with the regulations governing experimentation on humans, and
was approved by the University of Queensland Medical Research Ethics Committee (Australia).
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Reagents. All reagents were of analytical grade and obtained from Sigma or Melford Chemicals
unless otherwise indicated. -Glu-Cys and Cys-Gly were from BACHEM Peptides (Germany). The sulfate
and chloride salts of copper were used interchangeably. All reagents were prepared in deionized water.
Strains and culture conditions. GAS M1T1 5448 strains were propagated from frozen glycerol stocks
onto solid THY medium without any antibiotics. Unless otherwise indicated, liquid cultures were
prepared in a chemically defined medium containing glucose as the carbon source (CDM-glucose; see
Data Set S2A). This medium routinely contained 53 nM basal Cu, 155 nM Zn, 66 nM Fe, 9 nM Mn, 29 nM
Co, and 23 nM Ni, as determined by inductively coupled plasma mass spectrometry (ICP-MS). All solid and
liquid growth media contained catalase (50 g/ml).
Construction of mutants. Nonpolar GAS mutant strains were constructed by allelic exchange
following standard protocols (71). Primers and plasmids used in this study are listed in Data Set S2B. All
constructs and genetically altered strains were confirmed by PCR and Sanger sequencing.
Mice virulence assays. Transgenic, human plasminogenized AlbPLG1 mice heterozygous for the
human transgene were backcrossed greater than n  6 with C57BL/J6 mice as described previously (72).
GAS was prepared to obtain the target dose in the 107 CFU range (WT, 1.8 	 107; ΔcopA, 1.5 	 107)
immediately prior to injection. Mice were subcutaneously infected (n  10), and virulence was deter-
mined by observing survival for 10 days post-infection. Metal levels in mouse blood and skin were
measured by ICP-MS as described previously (73).
To assess GSH levels at the site of infection, mouse skin and infected lesions were excised 3 days
post-infection, washed with phosphate-buffered saline (PBS), resuspended in 1 ml of PBS, homogenized
in Lysing Matrix F tubes using a FastPrep 24G instrument (MP Biomedicals; 4°C, speed 6, 40 s, 2 cycles),
and centrifuged (10,000 	 g, 5 min, 4°C). Total GSH was measured from the supernatant using the
GSH-Glo kit (Promega) according to the manufacturer’s instructions, with the modification of mixing
undiluted samples 1:1 with 2 mM Tris(2-carboxyethyl)phosphine (TCEP) immediately prior to use.
Neutrophil-killing assays. Survival of GAS after incubation with human neutrophils ex vivo was
assayed at a multiplicity of infection of 10:1 as previously described (72).
Bacterial growth. Growth was assessed at 37°C in flat-bottomed 96-well plates using an automated
microplate shaker and reader. Each well contained 200 l of culture. Each plate was sealed with a gas
permeable, optically clear membrane (Diversified Biotech). OD600 values were measured every 20 min for
12 h. The plates were shaken at 200 rpm for 1 min in the double orbital mode immediately before each
reading. OD600 values were not corrected for path length (ca. 0.58 cm for a 200-l culture).
Plating efficiency. GAS was cultured in 96-well plates as described earlier for growth analysis,
sampled at the indicated time points, vortexed for 30 s, diluted serially in PBS, and plated onto solid THY
medium without any antibiotics. Colonies were enumerated after overnight incubation at 37°C.
ATP levels. GAS was cultured in 96-well plates as described earlier for growth analysis and sampled
at the indicated time points. The amount of total ATP in each sample was determined immediately using
the BacTiter-Glo kit (Promega).
Intracellular metal content. GAS was cultured in 10 to 500 ml of CDM-glucose as required (larger
volumes were required to obtain enough biomass at earlier time points). At the desired time points, an
aliquot was collected for the measurement of OD600 or plating efficiency. The remaining cultures were
harvested (5,000 	 g, 4°C, 10 min) and then washed once with PBS containing EDTA (1 mM) and twice
with ice-cold PBS. The final pellet was dissolved in concentrated nitric acid (150 l, 80°C, 1 h) and diluted
to 10 ml with deionized water. Total metal levels were determined by ICP-MS. The results were
normalized to OD600 values or plating efficiency as indicated in the figure legends.
Fermentation end products. GAS was cultured in 96-well plates as described earlier for growth
analysis. At the desired time points, samples were centrifuged (5,000 	 g, 4°C, 10 min) and the super-
natants were frozen at –20°C until further use. Concentrations of pyruvate, lactate, acetate, and ethanol
in the spent culture media were determined by using K-PYRUV, K-LATE, K-ACET, and K-ETOH kits
(Megazyme), respectively. Concentrations of glucose were determined using the GAGO20 kit (Sigma).
Enzyme activity. GAS was cultured in 40 to 250 ml of CDM-glucose as required (larger volumes were
required to obtain enough biomass at earlier time points). At the desired time points, bacteria were
harvested (5,000 	 g, 4°C, 10 min), washed once with PBS, and frozen at –20°C until further use. Bacterial
pellets were resuspended in a buffer containing sodium phosphate (100 mM) and triethanolamine
(80 mM) at pH 7.4, transferred to a tube containing Lysing Matrix B (MP Biomedicals), and lysed in a
FastPrep 24G instrument (MP Biomedicals, 10 m/s, 20 s, 2 cycles). Cell debris were removed by
centrifugation (20,000 	 g, 1 min). The cell-free lysate supernatant was kept on ice and used immedi-
ately.
To determine GapA activity, the reaction mixture contained NAD (4 mM), DL-glyceraldehyde-3-
phosphate (G3P; 0.3 mg/ml), sodium phosphate (100 mM), dithiothreitol (1 mM), and triethanolamine
(80 mM) at pH 7.4. GapN activity was determined as described above for GapA but using NADP (4 mM)
instead of NAD as the electron acceptor. To measure the activity of Ldh, the reaction mixture contained
NADH (4 mM), pyruvate (10 mM), and fructose-1,6-bisphosphate (1 mM) in PBS at pH 7.4. For all three
enzymes, each reaction (100 l) was initiated by addition of cell extracts (10 l). Absorbance values at
340 nm were monitored for up to 10 min at 37°C. The initial rates of reaction were normalized to total
protein content as determined using the QuantiPro BCA assay kit (Sigma). Control reactions without any
substrate (G3P for GapA and GapN, pyruvate for Ldh) were always performed in parallel.
One unit of activity was defined as follows: 1,000 nmol NAD oxidized min1 mg protein1 for GapA,
100 nmol NADP oxidized min1 mg protein1 for GapN, and 1,000 nmol NADH reduced min1 mg
protein1 for Ldh.
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GSH levels. GAS was cultured in 10 to 150 ml of CDM-glucose as required (larger volumes were
required to obtain enough biomass at earlier time points). At the desired time points, an aliquot was
plated for bacterial counting. The remaining cultures were harvested (5,000 	 g, 4°C, 10 min), washed
twice with PBS, resuspended in 5-sulfosalycylic acid (5 wt/vol %), transferred to a tube containing Lysing
Matrix B, and frozen at –20°C until further use. Bacteria were lysed in a bead beater (10 m/s, 30 s, 2 cycles).
Cell debris were removed by centrifugation (20,000 	 g, 1 min). Total GSH (and GSSG) levels in lysate
supernatants were determined immediately using the Gor-DTNB recycling method (74) and normalized
to total bacterial counts.
RNA extraction. GAS was cultured in 2 to 200 ml of CDM-glucose as required (larger volumes were
required to obtain enough biomass at earlier time points). At the desired time points, cultures were
centrifuged (3,000 	 g, 4°C, 5 min). Bacterial pellets were resuspended immediately in 1 ml of RNAPro
solution (MP Biomedicals) and stored at – 80°C until further use. Bacteria were lysed in Lysing Matrix B,
and total RNA was extracted according to the manufacturer’s protocol (MP Biomedicals). RNA extracts
were treated with RNase-Free DNase I enzyme (New England Biolabs). Complete removal of gDNA was
confirmed by PCR using gapA-check-F/R primers (see Data Set S2B). gDNA-free RNA was purified by using
an RNeasy minikit (Qiagen) and visualized on an agarose gel.
qPCR analyses. cDNA was generated from 1 g of RNA using the SuperScript IV first-strand synthesis
system (Invitrogen). qPCR was performed in 10- or 20-l reactions using 2 or 5 ng of cDNA as the
template and 0.4 M concentrations of the appropriate primer pairs (see Data Set 2B). Each sample was
analyzed in technical duplicates. Amplicons were detected with PowerUP SYBR green (Invitrogen) in a
QuantStudio 6 Flex real-time PCR system (Applied Biosystems) or a CFXConnect Real-Time PCR Instru-
ment (Bio-Rad Laboratories). Cq values were calculated using LinRegPCR after correcting for amplicon
efficiency. Cq values of technical duplicates were typically within 0.25 of each other.holB and tufA,
which encode DNA polymerase III and elongation factor Tu, respectively, were used as reference genes
(see Data Set S2B). Their transcription levels remained constant in all of the experimental conditions
tested here. holB was used as the reference gene in all the data presented here because its Cq values were
closer to the dynamic ranges of cop genes, adcAII, cadD, and siaA, but the results were identical with
when tufA was used as the reference.
RNA-seq analyses. GAS ΔcopA mutant strain was cultured in the presence of 0 or 5 M added Cu
for t  5 h (n  3), and RNA was extracted from each culture as described earlier. RNA-seq was performed
from Ribo-zero (rRNA-depleted) triplicate samples on a single Illumina HiSeq 2500 lane using v4
chemistry from 75-bp paired-end reads. Reads were mapped to the 5448 (M1) GAS reference genome
(GenBank accession number CP008776.1) with BWA MEM (v0.7.16). Relative read counts (per gene) and
differential gene expression was determined using DESeq2 (v1.26.0) (75) in R. Genes with fewer than 10
reads across all conditions and samples were removed. P values were calculated using Wald test and
adjusted for multiple testing using the Benjamini-Hochberg method for controlling the false discovery
rate. Illumina read data were deposited in the European Nucleotide Archive Sequence Read Archive
under accession numbers ERS1996831, ERS1996835, and ERS1996839.
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